Citations

Showing 10 of 107854 citations.

Dual Coronary Sinus Lead Strategy to Avoid Tricuspid Valve Traversal in Biventricular Pacing
Baqal, Omar , Liu, Michael B. , Rodriguez, Juan F. , Kanaan, Christopher , Somappa, Aakash , Estrada‐Vargas, Camilo A., Srivathsan, Komandoor, Rodriguez-Riascos, Juan F , Kanaan, Christopher N , Baqal, Omar J , Liu, Michael , Estrada-Vargas, Camilo A , Asirvatham, Samuel J. , Srivathsan, Komandoor

Mayo Clinic

Pacing and Clinical Electrophysiology | July 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/pace.70348 | PMID 42400389 Get It

ABSTRACT Patients requiring permanent pacing after tricuspid valve intervention present challenges due to the need to cross tricuspid valve prostheses. We report three cases of successful dual coronary sinus (CS) lead implantation for biventricular pacing following a range of tricuspid interventions—surgical tricuspid annuloplasty, transcatheter edge‐to‐edge repair, and transcatheter tricuspid valve replacement. The approach avoided tricuspid valve traversal, was technically feasible and resulted in satisfactory pacing performance without procedural complications. Dual CS lead configurations were individualized based on CS anatomy and pacing characteristics. The degree of QRS narrowing achieved varied according to lead location and ventricular activation patterns, highlighting the importance of individualized lead placement strategies and device programming. Dual CS lead pacing may represent a viable alternative for biventricular pacing in selected patients with prior tricuspid valve interventions. Larger studies are needed to evaluate long‐term outcomes and define the optimal role of this approach among available pacing strategies in this patient population.
Capsular Contributions to Hip Joint Stability: Clinical Anatomy and Implications for Surgical Management
Lu, Yining, Cabarcas, Brandon , Ahmad, Rana A. , Kelly, John J., Lachman, Nirusha , Nho, Shane, Hevesi, Mario, Cabarcas, Brandon C. , Kelly, John J., Krych, Aaron J. , Hevesi, Mario

Mayo Clinic

Clinical Anatomy | July 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1002/ca.70182 | PMID 42400381 Get It

ABSTRACT The hip capsule is a dense, fibrous structure that plays a crucial role in providing hip stability. Its biomechanical function is tied to its complex anatomy, which includes the iliofemoral, pubofemoral, and ischiofemoral ligaments, along with the circumferential fibers of the zona orbicularis. Anatomic and biomechanical studies with advanced imaging and arthroscopic techniques have provided better understanding of the capsular morphology and its contribution to hip stability. Additionally, these studies provide insight into how capsulotomy and subsequent capsular management at the time of hip arthroscopy can potentially influence postoperative outcomes. Growing clinical evidence supports capsular preservation and repair at the time of primary hip arthroscopy and demonstrates the potential negative outcomes of capsular deficiency, such as pain, dysfunction, and instability. This review provides a comprehensive overview of the gross, arthroscopic, radiologic, and biomechanical anatomy of the hip capsule.
Spatial and functional mapping of the human pancreas reveals endocrine and exocrine cell states in health and metabolic disease
Xie, Yike , Postić, Sandra , Ferrara, Roberta, Mullins, A. M. , Pfabe, Johannes, Dalman, Mercedes, Hallin, Kajsa, Ingvast, Sofie, Smith, Nancy, Tesi, Marta , Gyoeri, Georg, Dingfelder, Jule , Gironella-Torrent, Marta , MacDonald, Patrick E., Rupnik, Marjan S., Pereyra, David , Mullins, Alana, Pfabe, Johannes U. , Smith, Nancy , Suleiman, Mara , Györi, Georg, Starlinger, Patrick , Marselli, Lorella , Marchetti, Piero , MacDonald, Patrick E. , Rupnik, Marjan Slak , Korsgren, Olle , Camuñas-Soler, Joan

Mayo Clinic

No container title available | July 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.30.735261 Get It

Abstract The human pancreas contains diverse endocrine and exocrine cell populations whose spatial organization is essential for tissue physiology. While single-cell and spatial transcriptomics revealed molecular heterogeneity across pancreatic cell types, linking these states to physiological activity in situ has remained challenging. Here, we combined single-nucleus RNA sequencing, spatial transcriptomics, and functional calcium imaging across pancreatic samples in health and metabolic disease. We identified heterogeneous endocrine and exocrine cell states associated with obesity and diabetes, including inflammatory remodeling of acinar and ductal populations. To directly couple tissue physiology with molecular state, we developed Slice-seq, which integrates calcium imaging with spatial transcriptomics in acute pancreatic slices. Slice-seq linked local endocrine composition and transcriptional programs with β cell activity and identified extra-islet β cells with reduced glucose responsiveness and mitochondrial oxidative metabolism. Together, our study provides a framework for linking pancreatic cell states to tissue organization and physiological activity in health and disease.
SENTINOLD and the Challenge of Meaningful Risk Prediction in Melanoma
Meves, Alexander

Mayo Clinic

International Journal of Dermatology | July 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/ijd.70572 | PMID 42400123 Get It

Comparing those Most Satisfied Versus Least Satisfied Following Surgery for Cervical Spondylotic Myelopathy
Chan, Andrew K., Park, Christine , Shaffrey, Christopher I., Gottfried, Oren N., Than, Khoi D., Ef, Bisson, Williamson, Theresa , Bydon, Mohamad, Asher, Anthony L. , Coric, Domagoj , Potts, Eric A., Foley, Kevin T., Wang, Michael Y., Fu, Kai-Ming, Virk, Michael S. , Knightly, John J. , Meyer, Scott, Park, Paul, Upadhyaya, Cheerag, Yen, Chun-Po, Uribe, Juan S., Tumialán, Luis M., Turner, Jay, Chou, Dean, Haid, Regis W., Mummaneni, Praveen V., Chan, Andrew K. , Shaffrey, Christopher I. , Than, Khoi D. , Bisson, Erica F. , Bydon, Mohamad , Potts, Eric A. , Foley, Kevin T. , Wang, Michael Y. , Fu, Kai-Ming, Meyer, Scott, Yen, Chun-Po , Uribe, Juan S. , Tumialán, Luis M. , Turner, Jay D. , Chou, Dean , Mummaneni, Praveen V.

Mayo Clinic

Spine | July 3, 2026 | Volume: 51 | Issue: 15 | Pages: 1093-1100

10.1097/brs.0000000000005402 | PMID 42398026 Get It

Study Design. Post hoc analysis of prospectively-collected data. Objective. To identify factors predicting the most (and least) satisfaction following surgery for cervical spondylotic myelopathy (CSM). Summary of Background Data. Patient satisfaction affects long-term outcomes after surgery but the preoperative factors that influence postoperative satisfaction have not been well studied in patients with CSM. Methods. We conducted a post hoc analysis of prospectively-collected data from the Quality Outcomes Database (QOD) CSM registry cohort. Baseline and surgical characteristics were compared for patients with CSM reporting the most [North American Spine Society Satisfaction Score (NASS) 1] and least (NASS 4) satisfaction 24 months postoperatively. A multivariable logistic regression model was constructed using backward stepwise elimination to determine significant predictors of most versus least satisfaction. Twenty-four-month patient-reported outcomes (PROs) were compared. Results. Overall, 1141 patients were prospectively enrolled with 948 (83.1%) reaching 24-month follow-up. Of these, 699 met prespecified inclusion criteria: 610 (87.3%) were most satisfied and 89 (12.7%) were least satisfied. Though there were mean improvements in all 24-month PROs for the most satisfied cohort ( P <0.001), there were no significant improvements in 24-month PROs for the least satisfied cohort ( P >0.05). Using multivariable logistic regression modeling, a preoperative symptom of upper extremity weakness (OR=2.5, P =0.003), subjective myelopathy (OR=2.0, P =0.04), absence of numbness complaints (OR=2.2, P =0.003), symptom duration under 12 months (OR=1.6, P =0.047), Caucasian race (OR=2.3, P =0.001), participation in activities outside of the home (OR=2.0, P =0.04), anterior approach (OR=2.3, P <0.001), and higher baseline quality of life (OR=4.0, P =0.01) were predictive of the most satisfaction. Conclusion. Compared with the least satisfied, those most satisfied following surgery for CSM more often had a preoperative symptom of arm weakness, subjective myelopathy, the absence of numbness complaints, symptom duration under 12 months, higher baseline quality of life, and participation in activities outside of the home. Compared with a posterior approach, an anterior approach was associated with the most satisfaction. Taken together, early surgical treatment--before myelopathic symptoms significantly impact one's quality of life--may be considered to optimize patient satisfaction following CSM surgery.
Ventilator-Associated Pneumonia According to Chlorhexidine Oral Care Exposure in Patients With New Tracheostomy
Thompson, Hailey, Neiβ, A, Kooda, Kirstin, Shah, Aditya, Chalmers, Sarah, Cole, Kristin, Vollmer, Nicholas, Nei, Andrea, Kooda, Kirstin

Mayo Clinic

American Journal of Critical Care | July 3, 2026 | Volume: 35 | Issue: 4 | Pages: 289-297

10.4037/ajcc2026305 | PMID 42380032 Get It

Background Chlorhexidine is commonly used in prevention bundles for ventilator-associated pneumonia. Results for use of chlorhexidine in critically ill patients requiring mechanical ventilation via an endotracheal tube are mixed, and data for patients using a tracheostomy are lacking. Objectives To assess the risk for ventilator-associated pneumonia according to chlorhexidine exposure in patients requiring a new tracheostomy for mechanical ventilation. Methods This single-center, retrospective cohort study compared the development of ventilator-associated pneumonia according to chlorhexidine exposure in adult intensive care unit patients requiring new tracheostomy at a large academic medical center. Adults who received a new tracheostomy and required ventilator support for at least 48 hours were included. Patients treated for pneumonia at the time of tracheostomy or who met additional exclusion criteria were excluded. Results Of 235 patients who met the inclusion criteria, 203 received chlorhexidine and 32 did not. The cohort was predominantly White, male, and admitted to a surgical intensive care unit. Incidence of ventilator-associated pneumonia did not differ significantly between patients exposed or not to chlorhexidine (by 30 days, 32.5% vs 35.7%, P = .87). Time to development of ventilator-associated pneumonia also did not differ significantly between patients exposed or not (9 vs 12 days, respectively, P = .34). Conclusions Chlorhexidine exposure was not associated with a difference in the incidence of or time to ventilator-associated pneumonia after new tracheostomy. Further study is needed on the role of chlorhexidine in preventing ventilator-associated pneumonia after a new tracheostomy.
Novel Compounds as TREM2 Agonists for Treating Parkinson’s Disease, Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Nasu-Hakola Disease, and Stroke
Sabnis, Ram W. , Sabnis, Anika R.

Mayo Clinic

ACS Medicinal Chemistry Letters | July 3, 2026 | Volume: 17 | Issue: 8 | Pages: 1723-1724

10.1021/acsmedchemlett.6c00372 | PMID 42621473 Get It

Abstract Provided herein are novel compounds as TREM2 agonists, pharmaceutical compositions, use of such compounds in treating Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, frontotemporal dementia, Nasu-Hakola disease, and stroke, and processes for preparing such compounds.
Complete Imaging Resolution of Ductal Carcinoma In Situ During Osimertinib Therapy for Synchronous EGFR Exon 19-Mutant Non-Small Cell Lung Cancer: A Case Report
Sandoval, Letícia , Sharpe, Richard E. , Fullenkamp, Austin J., Downs, Erinn, Mina, Lida A. , Mina, Lida , Downs, Erinn

Mayo Clinic

International Journal of Molecular Sciences | July 3, 2026 | Volume: 27 | Issue: 13 | Pages: 5995

10.3390/ijms27135995 | PMID 42450262 Get It

A 64-year-old Asian woman diagnosed with synchronous breast ductal carcinoma in situ (DCIS) and stage IV EGFR-mutated non-small cell carcinoma of the lung (NSCLC). A decision was made to defer management of the DCIS and initiate Osimertinib for lung cancer treatment, since this was a life-limiting diagnosis. At 9 months, restaging FDG-PET CT showed an interval response in the NSCLC and complete loss of FDG avidity at the biopsy-proven DCIS site. Breast MRI confirmed complete imaging resolution of the DCIS. The clinical resolution of breast DCIS during third-generation EGFR inhibitor therapy has not been previously reported in humans and highlights a potential role for the EGFR/HER2 (ERBB) pathway in pre-invasive breast cancer.
Beyond diffusion and convection: is adsorption the third dimension of dialysis?
Kashani, Kianoush , Lentini, Paolo , Kashani, Kianoush B

Mayo Clinic

Nephrology Dialysis Transplantation | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ndt/gfag156 | PMID 42397143 Get It

A Novel Dosing Strategy for Tacrolimus in Lung Transplant Recipients: Integrating Machine Learning with Population Pharmacokinetic Analysis
Cai, Xiao-jun, Chen, Yan, Yang, Hang, Huang, Y N , Lu, Ying-rong, Zhou, Wen-Bo, Shi, Lingzhi , Chen, Jing-yu, Wu, B, Huang, Yuan, Li, Ziran , Li, Feng , Lu, Pei‐Hua

Mayo Clinic

Therapeutic Drug Monitoring | July 3, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/ftd.0000000000001495 | PMID 42397045 Get It

Background: Integrating machine learning (ML) with population pharmacokinetic (PPK) modeling may improve therapeutic drug monitoring predictions. Methods: Tacrolimus trough concentrations from lung transplant patients were split into a training data set (1151 concentrations in 80 patients) and a testing data set (224 concentrations in 20 patients). A PPK model was developed using NONMEM, followed by the development of 10 ML models to fit individual pharmacokinetic parameters from the PPK model with Bayesian forecasting. The best performing ML model was selected as the final model. Both the final PPK and ML models were compared for prediction performance. A web-based dashboard was established with R-shiny to recommend dosing regimens based on patient data. Results: In the PPK model, postoperative days, hematocrit, aspartate aminotransferase, tacrolimus daily dose, coadministered voriconazole or posaconazole, and the CYP3A5*3 genotype were identified significant covariates on the clearance. The Cubist ML model outperformed the PPK model, showing lower root mean squared error for tacrolimus concentrations in the testing data set. An online web-based precision dosing dashboard was created, accessible at (https://tac-dose-ml.shinyapps.io/shiny/). Conclusions: Integrating ML with PPK modeling could yield superior tacrolimus concentration predictions for lung transplant patients, offering an efficient alternative to Bayesian forecasting. The online dashboard provides rapid, individualized dosing recommendations.